Taken together, we concluded that ebastine exerts antitumor activity through the IPMK/AMPK/ULK1 signaling pathway in vivo. And the diagram of the mechanism of ebastine anti-osteosarcoma was shown in Figure 7e. Here, ULK1 is linked to osteosarcoma.